The verified answer
As of Sep 2026, DEPLOY verifies Stereotaxis: 1 model, 2 deployments across 2 regions, 1 active incident. 3 sources back the record.
Stereotaxis holds 1 FDA 510(k) clearance, per the DEPLOY registry.
See all 1 filingsCategorySurgical robots
Overview
Stereotaxis is an American medical device company based in St. Louis, Missouri, developing magnetic navigation technology for robotic cardiology procedures. Its Genesis RMN system uses robotically controlled magnets to guide flexible catheters with magnetic tips during cardiac ablation procedures, and received FDA clearance and NMPA approval in China.
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- 1 incident on file
Key facts
Product
Gating events
Stock listing
Installed base
Regulatory
Listed on
Data & sources
Press releases
3
3 sources backing this record.View all →
Models (1)
View all models →Stereotaxis on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jan 2026. Explore where Stereotaxis's robots are operating, by place and type.
View the full Stereotaxis deployment record →
Relationships
Current leadership (1)
- David Fischel Chairman & CEOreported, not verified
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Stereotaxis (1)
- FDA grants 510(k) clearance for Stereotaxis Synchrony system for digital cath lab2026-04-06 · Regulatory action
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- Stereotaxis2 deployments
Recent coverage
Stereotaxis in third-party press
Peers
41 peers across 1 segment. Every Stereotaxis competitor derived from shared form-factor and application-domain edges.
surgical robot(41)
28 companies in this segment · moderately_concentrated (HHI 2056.2102191459944) · leader Mazor Robotics at 3317%
- Asensus Surgicaldirect competitor(inferred)strong
- Brain Navidirect competitor(inferred)strong
- Brainlabdirect competitor(inferred)strong
- CMR Surgicaldirect competitor(inferred)strong
- Distalmotiondirect competitor(inferred)strong
- Intuitive Surgicaldirect competitor(inferred)strong
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Regulatory filings (1)
- fda_510kfda 510k · us_fdacleared2024-01-01
Linked models: Genesis RMN / GenesisX
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 5, 2026
Stereotaxis Genesis robotic magnetic navigation
- Record createdJun 3, 2026
Added to the verified registry
- Incident recordedApr 6, 2026
FDA grants 510(k) clearance for Stereotaxis Synchrony system for digital cath lab
- Deployment recordedJan 1, 2026
Genesis RMN / GenesisX at Global (multiple sites)
- Deployment verifiedVerifiedJan 1, 2019
Genesis RMN / GenesisX at United States
Sources (3)
Common questions
What is Stereotaxis?
What does Stereotaxis make?
Is Stereotaxis publicly traded?
Who competes with Stereotaxis?
Who is the CEO of Stereotaxis?
How can I invest in Stereotaxis?
Where is Stereotaxis headquartered?
Who owns Stereotaxis?
Where does Stereotaxis operate robots?
How many robots has Stereotaxis deployed?
Is Stereotaxis a top robotics company?
When was Stereotaxis founded?
Are there any incidents involving Stereotaxis?
Is Stereotaxis safe?
Methodology: Verified · 3 sources (3 primary) · last reviewed 2026-08-21
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 3
- primary-company-ir
- Company IR disclosure
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Stereotaxis.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
In the press
Recent coverage mentioning Stereotaxis from third-party publications. Automatically surfaced; not part of the verified registry record.
Stereotaxis completes acquisition of Robocath
Stereotaxis has announced that it has completed its previously announced acquisition of Robocath—an innovator of robotic technologies for interventional cardiology and…
Stereotaxis Next-Gen Endovascular Surgical Robot Receives 510k Clearance from FDA
Stereotaxis received FDA 510(k) clearance for its next-generation endovascular surgical robot, advancing minimally invasive cardiac procedures.
Stereotaxis Expands Endovascular Reach with 5M Robocath Acquisition
Stereotaxis acquired Robocath for 5M to expand its endovascular robotic surgery reach.
Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis
Stereotaxis received FDA clearance for the Genesis RMN system, a leap forward in Robotic Magnetic Navigation technology for cardiac procedures.
Machine-readable surfaces
- Markdown mirror: /companies/stereotaxis.md
- RSS feed: /companies/stereotaxis/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/e401d2c7-b035-4dea-9b60-ae0d2bb9b99b
- Revision history: /companies/stereotaxis/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Video
Robotic Magnetic Navigation (RMN) introduces the benefits of highly sophisticated robotics technology to allow for safe and effective cardiac ablation procedure
Hear from users of the latest generation of robotic catheter navigation technology, the Stereotaxis Genesis Robotic Magnetic Navigation system. In this summary
Stereotaxis presents the latest in Robotic Magnetic Navigation (RMN), the Genesis RMN system. Genesis is a leap forward in robotic technology and represents th
Silent video demonstrating the movement of the Stereotaxis robotic navigation system around the patient bedside.
Demonstration of the magnetically guided catheter navigating through several turns while maintaining maneuverability. Learn more about Stereotaxis Robotic Magne
Animation demonstration of how Stereotaxis robotically navigates the human body with the use of magnetic technology.
David Fischel, Chairman & CEO of Stereotaxis, breaks down the company’s bold R&D strategy and the three major innovations driving the future of robotic surgery.
#STXS, $STXS As part of my research in evaluating both stocks I own and and stocks I am considering taking a position in, I immerse myself in technical analysi
They’re letting robots put catheters inside people?! Today, we're talking to David Fischel, CEO at Stereotaxis. We discuss the revolutionary impact of robotic s
1. Nvidia partners with Stereotaxis to integrate AI into endovascular surgical robotics. 2. The GenesisX surgical robot system gains new capabilities with Nvidi
In this episode, we’re joined by Stereotaxis CEO David Fischel, who shares the remarkable story of his company’s journey. Discover how Stereotaxis is revolution
Get it? Attractive? Magnets. Yeh, we’ll, we’re tired from putting this monster podcast episode together but it’s so, so good. You’ll hear from David Fischel,
Today's SSI MedTech "In the News Development" is brought to you by SSI President Darwin Shurig. Darwin discusses Stereotaxis and their new Genesis Robotic Magne
Heat Index
Serious50/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Stereotaxis draws attention at the 58th percentile but verifies reality at the 64th percentile among surgical robots. Hype Gap -6.4, 27th widest among surgical robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 2, 2026